
EU GMP Annex 22: AI Pulse Check panelists say most manufacturers aren’t ready, static AI models likely stay central, and local AI deployment grows.
Click the title above to open the Pharmaceutical Technology October 2017 issue in an interactive PDF format.
about 9 years ago
Managing Potentially Potent APIsabout 9 years ago
Pharma’s Role in Puerto Rico’s Futureabout 9 years ago
Starting Early is Key to De-Risking Drug Developmentabout 9 years ago
Formulation Strategies in Early-Stage Drug Developmentabout 9 years ago
Pharmaceutical Environmental Pollution and Antimicrobial Resistanceabout 9 years ago
A Closer Look at Prefilled Syringesabout 9 years ago
FDA User Fees Promote Manufacturing Readinessabout 9 years ago
Testing and Simulation Approaches for Single-Use Bioreactor Scale-upabout 9 years ago
Up and Away, M&Aabout 9 years ago
Making Decisions Based on Risk




